Portfolio Companies News
November 18, 2019Strongbridge Biopharma plc Announce...
~ The Company Remains Focused on Completing the LOGICS Study and Submitting a New Drug Application (NDA) for RECORLEV™ (levoketoconazole), While Ensuring Continued Growth and Profitability of KEVEYIS® (dichlorphenamide) and Serving the Unmet Needs of the Primary Periodic Paralysis Community ~ ... read more
November 13, 2019Nordic Nanovector ASA: Invitation t...
Oslo, Norway, 13 November 2019 Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the third quarter 2019 on Tuesday, 19 November 2019. A presentation by Nordic Nanovector's senior management team will take place at 8:30am CET at: Thon Hotel Vik... read more
November 13, 2019Vicore Pharma has completed a direc...
2019-11-13 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, THE UNITED KINGDOM, CANADA, HONGKONG, JAPAN, SWITZERLAND, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE THE PUBLICATION, DISTRIBUTION OR RE... read more
November 12, 2019BONESUPPORT appoints Fergus MacLeod...
Lund, Sweden, 16:00 CET, November 12 2019BONESUPPORT™ an emerging leader in orthobiologics for the management of bone injuries, announces changes in its leadership team that will take place November 18, 2019. Fergus MacLeod starts in the position as the company's General Manager & Executive... read more
November 12, 2019Strongbridge Biopharma plc to Prese...
DUBLIN, Ireland and TREVOSE, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announc... read more
October 31, 2019Q3 2019 General Market Overview
Since the start in 1996, HealthCap funds have invested in 114 portfolio companies.
43 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.